908 Devices Inc.

Listed Company

MASSCIK 0001555279NasdaqNon-AcceleratedSmaller ReportingMeasuring & Controlling Devices, NecDelawareFY ends Dec 31

Period

FY 2025

Revenue

$56.20M

Net Income

$19.49M

Total Assets

$190.07M

Equity

$143.70M

Shares Out

37.38M

Op. Cash Flow

$-23.69M

Business

908 Devices Inc. develops and commercializes purpose-built handheld and desktop analytical devices that bring molecular chemical and biochemical analysis to the point-of-need. Its main products leverage microscale mass spectrometry, optical spectroscopy (FTIR), microfluidics, and embedded analytics/machine learning to identify, separate and quantify trace and bulk chemical species, sold as devices such as MX908, ThreatID, ProtectIR, Rebel, Maverick, Maven, ZipChip Interface and related consumables and services. Key business segments include forensic and public safety applications, bioprocess monitoring and control, pharmaceutical/biopharma and life‑science research solutions. The company sells worldwide through direct field sales and a global network of channel partners, supporting government, industrial and academic customers.

Summary from filing dated 2025-03-07

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	56	48	50	47	42
Cost of revenue	28	23	25	21	19
Gross profit	28	25	25	26	23
Research and development	16	15	22	18	13
Selling, general and administrative	39	39	46	44	32
Change in fair value of contingent consideration	14	−13	107,000	—	—
Goodwill impairment	—	41	—	—	—
Total operating expenses	68	82	68	61	45
Loss from continuing operations	−39	−57	−43	−35	−22
Interest income	4	4	6	2	548,000
Income from transition services agreement, net	2	—	—	—	—
Other expense, net	−346,000	−241,000	−131,000	−83,000	−162,000
Total other income, net	6	4	6	2	−100,000
Loss from operations before income taxes	−33	−53	−37	−34	—
Income tax expense	66,000	300,000	200,000	0	—
Net loss from continuing operations	−33	−53	—	—	—
Net income (loss) from discontinued operations, net of tax	53	−19	—	—	—
Net income (loss) attributable to common stockholders	19	−72	−36	−34	−22
Net loss from continuing operations per share attributable to common stockholders, basic	−0.93	−1.56	—	—	—
Net loss from continuing operations per share attributable to common stockholders, diluted	−0.93	−1.56	—	—	—
Net income (loss) from discontinued operations per share attributable to common stockholders, basic	1.47	−0.56	—	—	—
Net income (loss) from discontinued operations per share attributable to common stockholders, diluted	1.47	−0.56	—	—	—
Net income (loss) per share attributable to common stockholders, basic	0.54	−2.12	−1.13	−1.07	−0.79
Net income (loss) per share attributable to common stockholders, diluted	0.54	−2.12	−1.13	−1.07	−0.79
Weighted average common shares outstanding, basic	36	34	32	31	28
Weighted average common shares outstanding, diluted	36	34	32	31	28

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2024 2024-06-30	FY 2023 2023-12-31	FY 2022 2022-12-31
Cash and cash equivalents	71	44	—	121	188
Cash and cash equivalents from continuing operations	—	43	—	—	—
Marketable securities	42	26	—	25	—
Accounts receivable, net of allowance for credit losses of $147 and $524 at December 31, 2025 and December 31, 2024	11	9	—	9	10
Inventory	13	11	—	15	13
Prepaid expenses and other current assets	7	4	—	4	5
Current assets of discontinued operations	—	10	—	—	—
Total current assets	145	103	—	174	216
Operating lease, right-of-use assets	4	4	600,000	6	4
Property and equipment, net	4	2	—	3	3
Intangible assets, net	36	39	—	8	8
Other long-term assets	471,000	511,000	—	1	1
Non-current assets of discontinued operations	—	12	—	—	—
Total assets	190	159	—	203	243
Accounts payable	2	1	—	1	1
Accrued expenses	7	7	—	9	9
Deferred revenue	9	10	—	11	8
Operating lease liabilities	681,000	1	—	2	1
Contingent consideration	16	—	—	—	—
Current liabilities of discontinued operations	—	5	—	—	—
Total current liabilities	34	25	—	23	19
Operating lease liabilities, net of current portion	4	3	—	4	3
Deferred revenue, net of current portion	8	10	—	9	11
Contingent consideration, net of current portion	—	2	—	—	—
Other long-term liabilities	30,000	2	—	—	555,000
Non-current liabilities of discontinued operations	—	5	—	—	—
Total liabilities	46	45	—	37	52
Commitments and contingencies (Note 17)	—	—	—	—	—
Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued or outstanding at December 31, 2025 and December 31, 2024, respectively	—	—	—	—	—
Common stock, $0.001 par value; 100,000,000 shares authorized; 36,321,866 shares and 35,098,493 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively	36,000	35,000	—	33,000	32,000
Additional paid-in capital	367	356	—	335	324
Accumulated other comprehensive income	54,000	1	—	1	798,000
Accumulated deficit	−223	−243	—	−171	−134
Total stockholders' equity	144	115	—	165	191
Total liabilities and stockholders' equity	190	159	—	203	243

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net income (loss)	19	−72	−36	−34	−22
Depreciation and amortization expense	4	5	2	2	925,000
Stock-based compensation expense	10	12	10	7	3
Provision for inventory obsolescence	513,000	653,000	663,000	376,000	191,000
Net amortization of premiums and accretion of discounts on marketable securities	−637,000	13,000	−301,000	—	—
Loss on disposal of property and equipment	133,000	54,000	—	—	—
Gain on sale of Desktop Portfolio, net of transaction costs	−56	—	—	—	—
Provision for credit losses	—	176,000	386,000	—	—
Change in fair value of contingent consideration	14	−13	107,000	161,000	—
Deferred income tax	—	−283,000	−305,000	−129,000	—
Accounts receivable, net	220,000	−3	680,000	6	−11
Inventory	−4	−2	−4	−5	−4
Prepaid expenses and other current assets	−3	−445,000	−513,000	844,000	−4
Other long-term assets	211,000	559,000	−135,000	−93,000	−476,000
Accounts payable and accrued expenses	−6	2	2	452,000	3
Deferred revenue	−3	−368,000	179,000	2	5
Right-of-use operating lease assets	2	2	2	1	1
Operating lease liabilities	−2	−2	−2	−1	−1
Net cash used in operating activities	−24	−30	−25	−21	−29
Purchases of property and equipment	−955,000	−602,000	−2	−2	−737,000
Purchases of marketable securities	−64	−56	−49	—	—
Acquisition of businesses, net of cash acquired	−2	−45	—	—	—
Proceeds from sale of Desktop Portfolio	70	—	—	—	—
Proceeds from maturities of marketable securities	48	55	25	—	—
Net cash provided by (used in) investing activities	51	−46	−26	−16	−737,000
Payments for withholding taxes on vested awards	−833,000	−1	−776,000	−262,000	—
Proceeds from issuance of common stock	864,000	1	936,000	2	852,000
Payments for contingent consideration	−728,000	−417,000	−1	—	—
Net cash used in financing activities	−697,000	−376,000	−16	1	95
Effect of foreign exchange rate changes on cash and cash equivalents	27,000	−65,000	13,000	18,000	—
Net increase (decrease) in cash, cash equivalents and restricted cash	26	−77	−67	−36	65
Transfers of inventory to property and equipment	983,000	1	1	887,000	940,000
Fair value of common stock issued for acquisition of RedWave Technology	—	9	—	—	—
Cash (received) paid for income tax	−66,000	184,000	—	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro